Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Squatrito

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature|August 31, 2007
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage responseChiara Gorrini, Massimo Squatrito, Chiara Luise, et al.
Nature Communications|August 6, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasBarbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, et al.
Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Cancers|January 22, 2021
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in GlioblastomaPaula Aldaz, Jaione Auzmendi-Iriarte, Maika Durántez, et al.
Nature Communications|June 13, 2019
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8<sup>+</sup> T cell tumor-infiltration impairing anti-PD1 therapyMónica Pascual-García, Ester Bonfill-Teixidor, Ester Planas-Rigol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
Neuro-Oncology|December 24, 2025
Subtype selective PET imaging of PARP1 binding in non-human primates, healthy volunteers and patients with glioblastoma using [11C]AZ14193391Zsolt Cselényi, Aurelija Jucaite, Giuseppe Stragliotto, et al.
JCI Insight|April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomasVirginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Nature|June 22, 2022
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4Laura Campisi, Shahab Chizari, Jessica S Y Ho, et al.
Nature Structural & Molecular Biology|September 5, 2018
Influenza virus infection causes global RNAPII termination defectsNan Zhao, Vittorio Sebastiano, Natasha Moshkina, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature|August 31, 2007
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage responseChiara Gorrini, Massimo Squatrito, Chiara Luise, et al.
Nature Communications|August 6, 2020
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomasBarbara Oldrini, Nuria Vaquero-Siguero, Quanhua Mu, et al.
Nature Communications|December 13, 2017
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancerBarbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, et al.
Cancers|January 22, 2021
Identification of a Dexamethasone Mediated Radioprotection Mechanism Reveals New Therapeutic Vulnerabilities in GlioblastomaPaula Aldaz, Jaione Auzmendi-Iriarte, Maika Durántez, et al.
Nature Communications|June 13, 2019
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8<sup>+</sup> T cell tumor-infiltration impairing anti-PD1 therapyMónica Pascual-García, Ester Bonfill-Teixidor, Ester Planas-Rigol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2025
Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate CancerHarveer Dev, Mark Linch, Krishna Narahari, et al.
Neuro-Oncology|December 24, 2025
Subtype selective PET imaging of PARP1 binding in non-human primates, healthy volunteers and patients with glioblastoma using [11C]AZ14193391Zsolt Cselényi, Aurelija Jucaite, Giuseppe Stragliotto, et al.
JCI Insight|April 8, 2022
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomasVirginia Laspidea, Montserrat Puigdelloses, Sara Labiano, et al.
Nature|June 22, 2022
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4Laura Campisi, Shahab Chizari, Jessica S Y Ho, et al.
Nature Structural & Molecular Biology|September 5, 2018
Influenza virus infection causes global RNAPII termination defectsNan Zhao, Vittorio Sebastiano, Natasha Moshkina, et al.
Pageof 5